Skip to main content
Acta Pharmacologica Sinica logoLink to Acta Pharmacologica Sinica
. 2022 Aug 22;44(3):693–694. doi: 10.1038/s41401-022-00979-3

Author Correction: Galectin-3 gene silencing inhibits migration and invasion of human tongue cancer cells in vitro via downregulating β-Catenin

Dong Zhang 1,2, Zheng-gang Chen 3, Shao-hua Liu 1,2, Zuo-qing Dong 1, Martin Dalin 4, Shi-san Bao 5, Ying-wei Hu 2,, Feng-cai Wei 1,2,
PMCID: PMC9958193  PMID: 35995869

Correction to: Acta Pharmacologica Sinica 10.1038/aps.2012.150, published online 29 October 2012

During recent check of our article entitled “Galectin-3 gene silencing inhibits migration and invasion of human tongue cancer cells in vitro via downregulating β-Catenin” published in Acta Pharmacologica Sinica, we found that there were several mistakes in the final assemble of figures: (1) in Fig. 2B, figures of Untreated and Gal-3-siRNA of SCC-4 at 0 h were selected from the same group of CAL27 respectively, and the figure of Control-siRNA of SCC-4 at 48 h was from the Untreated group of SCC-4 at 48 h; (2) in Fig. 2B, the figure of Control-siRNA of CAL27 at 48 h was wrongly selected; (3) in Fig. 2C, the figure of Control-siRNA of CAL27 was selected from the same group of SCC-4. Although the mistakes resulted from our carelessness in the process of assembling figures due to the similarity of the involved figures, the conclusions of the original article or the text of the article and the figure legends were not affected. We apologize sincerely for any inconvenience caused.

Fig. 2. Effects of Gal-3 silencing on tumor cell biological characteristics.

Fig. 2

There was no differences in cell proliferation between control and experimental groups in any of the cell lines (A. Gal-3 siRNA vs controls, PSCC-4 = 0.509; PCAL27 = 0.366). However, scratch assay demonstrated that cell migration was dramatically decreased in experimental groups after Gal-3-siRNA transfection (B). Cell invasion was decreased in cells treated with Gal-3-siRNA, when compared with the control groups (C. Gal-3 siRNA vs controls, cPSCC-4 < 0.01; cPCAL27 < 0.01).

The corrected figures are as shown above

Contributor Information

Ying-wei Hu, Email: Huyingwei@sdu.edu.cn.

Feng-cai Wei, Email: weifengcai2012@163.com.


Articles from Acta Pharmacologica Sinica are provided here courtesy of Nature Publishing Group

RESOURCES